Drug metabolism and disposition: the biological fate of chemicals

How the Body and Gut Bacteria Work Together to Produce Trimethylamine and Its Related Compound, Influencing Health and Disease

Updated

Abstract

Flavin-containing monooxygenase 3 (FMO3) is responsible for converting trimethylamine (TMA) into nonodorous TMA N-oxide (TMAO), which is excreted in urine.

  • Impaired FMO3 activity leads to primary trimethylaminuria (TMAU), resulting in excessive excretion of TMA.
  • Dysbiosis in gut bacteria can contribute to secondary TMAU by altering TMA production.
  • Dietary components significantly influence TMA levels through their interaction with gut bacteria.
  • TMAO, the product of FMO3 activity, may be linked to various health conditions, including cardiovascular disease and metabolic disorders.
  • The microbiome-host axis involving TMA and TMAO is critical for understanding health and disease management.

Simplified

Full Text

We can’t show the full text here under this license.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free